Assist. Prof. Dr. Mesut Sancar, PhD
Contact Education Cources Memberships Research Areas Publications Presentations Workshops Thesis Projects Awards					Türkçe English
Contact Information
E-mail			sancarmesutyahoo.com mesut.sancarmarmara.edu.tr mesutsancar@klinikecza.org
Phone			+90 216 346 40 60 +90 216 414 29 62 / 187
Fax			+90 216 345 29 52
Mail address			Marmara Üniversitesi Eczacılık Fakültesi Klinik Eczacılık Bilim Dalı Tıbbiye Cad. No. 49  Haydarpaşa  34668  İstanbul
			Top
Education
PhD			1996 – 2002:  Clinical pharmacy A pharmacoeconomic study of Helicobacter pylori eradication and prevention of nonsteroidal antiinflammatory drug induced ulcers in rats.
MSc			1993 – 1995:  Clinical Pharmacy Study The Effects of Ketorolac On Renal and Hematological Parameters
BSc			1988 – 1992: Istanbul University, Faculty of Pharmacy
Training			Clinical Pharmacy Practices in M.Ü. Hospital, 1993-1997. Hospital Pharmacy Training in International Hospital, July 1993. Clinical Pharmacy Practices in Omaha- Nebraska, ABD, October-December 1998.
Certificate Programs			Pharmacoeconomics, European Association for Clinilal Pharmacology and Therapeutics, İstanbul 2003. Pharmacoepidemiology, European Association for Clinilal Pharmacology and Therapeutics, İstanbul 2003.
			Top
Memberships
1. Society of Clinical Pharmacy in Turkey - Founder member and Executive Board, 1998-…. 2. European Society of Clinical Pharmacy – 2002-….. 3. Society of Trombosis, Hemostasis and Angiology – 2006-….
				Top
Courses Given
Undergraduate
		Clinical Pharmacy I
		Clinical Pharmacy II
		Clinical Pharmacy II Hospital Practice
MSc Programs
		Role of The Clinical Pharmacist and Pharmaceutical Care
		Drug Information for Health Profesiionals
		Case Presentations I-II
		Applied Clinical Pharmacy I-II
		Clinical Pharmacy and Pharmacotherapy
		Role of The Pharmacist in Treatment of Infectious Diseases
		Clinical Pharmacy Practices in Community Pharmacy I-II
		Clinical Pharmacy in Hospital Services I-II
PhD Program
		Clinical Pharmacy and Therapy I-II
		Pharmacotherapy
		Pharmacoeconmics
		Clinical Pharmacy and Internal Medicine I-II
		Oncology Pharmacist
		Clinical Pharmacist in Obstetrics and Gynecology
		Patient Education
		Clinical Pharmacist in Pediatrics
		Pharmaceutical Care
CE Programs
		Role of the pharmacists in upper respiratory tract infections. İstanbul, Ankara and İzmit 2002-2004
		Clinical Pharmacy and Pharmaceutical Care I: Patient Education, MUSEM Seminars, İstanbul, 2001.
		Clinical Pharmacy and Pharmaceutical Care II: Gastrointestinal Infections, MUSEM Seminars İstanbul, 2002.
		Basic Principles of Pharmacoeconomics, İstanbul, 2002.
		Role of the pharmacist in diarrhea treatment and muscle relaxant use. Antalya, Gaziantep, İzmir, Sivas, Bursa 2004-2005
		Good Pharmacy Practices – Clinical Pharmacy – Pharmaceutical Care Seminars. 2003-….. Turkish Pharmacist Association, Ankara, Mersin and İstanbul
		Role of the pharmacists in infection diseases, 2005-…. Turkish Pharmacist Association, Ankara, Mersin and İstanbul
		Role of The Pharmacist in Endocrin and Rheumatology, 2007-… Turkish Pharmacist Association, Ankara
		Pharmacy Technician Programs, 2005-…, İstanbul and Bursa.
		Consultant Pharmacist in Chronic Diseases – Society of Clinical Pharmacy, 2006-…, İstanbul.
		Top
Current Research Areas
Pharmaceutical Care and Patient Education Gastrointestinal System Diseases and Treatments NSAIDs and side effects Pharmacoeconomics Tuberculosis
Top
Publications
Articles in International Scientific Journals
1	M. Sancar, F.V. İzzettin, A. Gümüş, M. Ş. Uğur, A. R. Uras, U. Çevikbaş, S. J. Stohs: Effects of Ketorolac on Renal and Hematological Parameters. Research Communication in Pharmacology and Toxicology, 3 (3-4): 114-122, 1998.
2	E.Y. Ahmed, F.V. İzzettin, B. Ayça, M. Sancar, S.J. Stohs: Nephrotoxicity of Piroxicam in Rats. Research Communication in Pharmacology and Toxicology, 8(1-2): 27-33, 2003.
3	S.Apikoglu Rabus, F.V. Izzettin, M. Sancar, C. Yakut: Cost-Effectiveness of Thrombolytics: A Simplified Model. Pharm World Sci. 27(3): 243-248, 2005.
4	B. Okuyan, F.V. İzzettin, , M .Sancar, O. Ertas, U.S. Gurer, A. Cevikbas: Effect of antituberculous drugs on human polymorphonuclear leukocyte functions in vitro. Int Immunopharmacol. 5(7-8):1337-42, 2005.
5	S. Unsalan, M. Sancar, B. Bekce,P.M. Clark, T. Karagoz, F.V. Izzettin, S. Rollas: Therapeutic Isoniazid, Pyrazinamide and Rifampicin Monitoring Using High Performance Liquid Chromatography in Tuberculosis Patients. Chromotographia. 61(11-12): 595-598, 2005.
6	M. Sancar, F.V. İzzettin, Ş. Rabuş, F. Beşışık, N. Tözün, G. Dülger: Pharmacoeconomic Comparison of Helicobacter Pylori Eradication Regimens. Pharm World Sci, 28: 207-214, 2006
Articles in Natinoal Scientific Journals
1	B. Ayça, M. Sancar, F.V. İzzettin: Egzersize Bağlı Astım ve Sporcuların Bu konuda Eğitilmesi. Mar. Üniv. Ecz. Der., 12 (2): 85-95, 1996.
2	E. Bayrakdar, M. Ercan, M. Sancar, A. Uras, İ. Beycan: The Effects of Irradiation on Red Blood Cell Deformability. J Marm Pure Appl Sci, 17: 17-22, 2001.
3	K. Demirkan, A. Çeliker, D. Yılmaz, M. Sancar, S. Apikoglu Rabus, F.V. İzzettin, F. Şahin: Improvement in Pharmacists’ Knowledge Through Professional Inservice Education Programs. FABAD J. Pharm. Sci., 29: 117-120, 2004.
4	FV. İzzettin, Ş. Apikoğlu Rabuş, M. Sancar, A. Eskisar: Coronary Artery Disease Prediction in Men: Use of Apolipoproteins A-1 and B. FABAD J.Pharm. Sci. 30, 134-140, 2007.
Publications in National Pharmacy Journals
1	M. Özsavcı, S. Tunç, M. Sancar, F.V. İzzettin: Eczacılık Eğitimi ve Vaka Takdimi. V. Türkiye Eczacılık Kongresi Kitapçığı, s: 124-130, İstanbul, 1993.
2	M. Sancar, F.V. İzzettin: Bronşial Astım. Klinik Eczacılık MİEP Kitapçığı, s: 82-89, Ankara Eczacı Odası, Ankara, 1994.
3	M. Sancar, F.V. İzzettin: Ağrı Tedavisinde Klinik Eczacının Rolü. Eczane-Parfümeri, 56: 2-5, 1995.
4	M. Sancar, F.V. İzzettin: İlaç Kaynaklı Renal ve Hematolojik Bozukluklar. Güncel Eczacılık, 32: 16-18, 1995.
5	F.V. İzzettin, N. Özdinç, M. Sancar: Klinik Eczacılık ve İlaç Danışmanlığı. Eczane-Parfümeri Dergisi, 83: 28-30, 1997.
6	F.V. İzzettin, M. Sancar: Genel Hatlarıyla Klinik Eczacılık. Genç Havan, Mayıs Özel Sayısı: 14-18, 1999.
7	F.V. İzzettin, M. Sancar: Dünyada Eczacılık Eğitimi. Hedef Sağlık, 5: 12-15, 2001.
8	M. Sancar, FV. İzzettin: Hasta Eğitiminin Önemi. MİSED, 5-6: 10-12, 2003.
9	H. Cömerter, M. Sancar, F.V. İzzettin: Soğuk Algınlığı Tedavisinde Eczacının Rolü. MİSED 5-6: 14-19, 2003.
10	F.V. İzzettin, M. Sancar: Klinik Eczacılık Nedir? Pharmagap. 7: 33-35, 2004.
11	M. Sancar, F.V. İzzettin: Klinik Eczacılıkta Yeni Girişimler. Denge, 1: 36-39, 2004.
12	M. Sancar, F.V. İzzettin: Astım Tedavisinde Klinik Eczacının Rolü. PharmaKaradeniz, 1: 10-13, 2004.
13	M. Sancar, F.V. İzzettin: Diyabet ve Klinik Eczacılık. Dergi EDAK, 1: 33-35, 2005
14	M. Sancar, S. Ünsalan: Eczacılık Eğitimi. Sağlıkta Nabız, 4(17): 46-47, 2005.
15	M. Sancar, F.V. İzzettin: Avrupa’da Klinik Eczacılık ve Farmasötik Bakım. Hedef Sağlık, 27:24-26, 2006.
Lecture Notes
	Good Pharmacy Practices – Clinical Pharmacy – Pharmaceutical Care. Turkish Pharmacist Association, 2003
	Role of the pharmacists in infection diseases. Turkish Pharmacist Association -2005.
	Role of The Pharmacist in Endocrin and Rheumatology. Turkish Pharmacist Association -2007.
	Pharmaceutical Care in Diabetes – Society of Clinical Pharmacy - 2007
	Top
Presentations
International Presentations
1	M. Sancar, F.V. İzzettin, A. Gümüş, M. Ş. Uğur, A. R. Uras, U. Çevikbaş: Effects of Higf Dose of Ketorolac on Renal and Hematological Parameters. III. Ulusal (Uluslar arası katılımlı) Eczacılık Kongresi, Sofya, 1996.
2	N. Özdinç, M. Sancar, P. Clark, F.V. İzzettin: In vitro Evaluation of Naproxen Dosages Forms Available on Turkish Market. Second International Meeting on Pharmacy and Pharmaceutical Sciences, Istanbul, 1998.
3	M. Sancar, F.V. İzzettin, A. R. Uras, U. Çevikbaş: Effects of Ketorolac on Renal and Hematological Parameters. Second International Clinical Pharmacy Conference, Amman, 1999.
4	Sancar M, İzzettin FV, Beşışık F, Tozun N, Dulger G: Pharmacoeconomic comparison of Helicobacter pylori eradication regimens. 31^st European Symposium on Clinical Pharmacy, Florence, Italy, 2002.
5	S. Ünsalan, B. Bekçe, M. Sancar, F. Vehbi İzzettin, S. Rollas: Determination of Isoniazid, Pyrazinamide and Rifampicin by HPLC. 1^stInternational Meeting on Medicinal and Pharmaceutical Chemistry. Ankara, 2002.
6	S. Unsalan, B. Bekçe, M. Sancar, FV İzzettin, S. Rollas: Therapeutic Drug monitoring (TDM) in tuberculosis patients. 8th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Basel-Switzerland, 7-11 September 2003.
7	M. Sancar, F.V. İzzettin, F. Beşışık, N. Tözün, G. Dülger: Pharmacoeconomic Evaluation of Helicobacter Pylori Eradication Regimens. 7^th Internation Symposium on Pharmaceutical Science. Ankara 2003. Oral Presentation
8	K. Demirkan, D. Yilmaz, M. Sancar, F.V. İzzettin, S. Apikoglu-Rabus: Improvement of pharmacists’ knowledge with continuing education programs. 2nd ACCP-ESCP International Congress on Clinical Pharmacy. Paris 2004.
9	M. Turnacular, M. Sancar, S. Apikoglu Rabus, N. İzzettin, E. Turnacılar, F.V. İzzettin: Outcomes of Pharmaceutical Care in Type II Diabetes: Patient Education and Monitoring. 33^rd European Symposium on Clinical Pharmacy, Prague, 2004. Oral Presentation
10	S.Apikoglu Rabus, M. Sancar, A. Eskisar, F. Turan, C. Yakut, F.V. İzzettin: Prescription profiles in primary and secondary coronary artery disease prevention. 33^rd European Symposium on Clinical Pharmacy, Prague, 2004.
11	B. Okuyan, F.V. İzzettin, A. Cevikbas, M.Sancar, U.S. Gurer: An in vitro investigation of the effect of antituberculous drugs on functions of polymorphonuclear leukocyte. 33^rd European Symposium on Clinical Pharmacy, Prague, 2004.
12	S.Apikoglu Rabus, M.B. Rabus, M. Sancar, A. Eskisar, M. Ozkan, C. Yakut, F.V. İzzettin: Prescription profiles in primary and secondary coronary artery disease prevention. 17^th Annual Meeting of the Mediterranean Association of Cardiology and Cardiovascular Surgery, Slovenia, 2005.
13	S. Apikoglu Rabus, F. V. Izzettin, M. Sancar, O. Karakaya, R. Kargin, C. Yakut : Mid-term results of secondary prevention in coronary artery disease : drug utilization profiles. 6^th ESCP Spring Conference, Vilnius, Lithuania, 2006. Oral Presentation
14	S. Apikoglu Rabus, F. V. Izzettin, M. Sancar, O. Karakaya, R. Kargin, C. Yakut : Mid-term results of secondary prevention in coronary artery disease : drug utilization profiles. 8^th International Symposium on Pharmaceutical Sciences, Ankara, Turkey, 2006.
15	M. Sancar, F. V. İzzettin, M. Hursitoglu, U. Cevikbas: Different models in nonsteroidal anti-inflammatory drug induced ulcers prevention in rats. 8^th International Symposium on Pharmaceutical Sciences, Ankara, Turkey, 2006.
16	T. Hantash, M. Sancar, B. Okuyan, Z. Cirakli, U. Cevikbas, F. Uras, F. V. İzzettin: Comparison of the effect of Glycyrrhiza glabra with different antiulcer drugs on aspirin induced ulcer in rats. 8^th International Symposium on Pharmaceutical Sciences, Ankara, Turkey, 2006.
17	M. Sancar, B. Okuyan, S. Apikoğlu Rabus, F.V. Izzettin: Community pharmacists’ opinion on pharmaceutical care practice in Turkey. 7^th ESCP Spring Conference, Edinburgh, UK, 2007.
18	F.V. Izzettin, V.S. Nakiboglu, M. Sancar: The quality of life and pharmaceutical care requirements of the hypertension patients in a community pharmacy. 7^th ESCP Spring Conference, Edinburgh, UK, 2007.
National Presentations
1	M. Özsavcı, S. Tunç, M. Sancar, F.V. İzzettin: Eczacılık Eğitimi ve Vaka Takdimi. V. Türkiye Eczacılık Kongresi, İstanbul, 1993. Oral Presentation
2	M. Sancar, F.V. İzzettin, M. Ş. Uğur, A. R. Uras, U. Çevikbaş: Ketorolakın Renal ve Hematolojik Parametrelere Etkisi. XXIV. Ulusal Hematoloji Kongresi, İstanbul, 1996. Oral Presentation
3	M. Sancar, F.V. İzzettin: ABD’de Klinik Eczacılık Uygulamaları. IV. Kamu Eczacıları Kurultayı, Ankara, 1999. Oral Presentation
4	M. Sancar: Farmakoekonomiye Genel Bakış. VII. Türkiye Eczacılık Kongresi, 2003 İstanbul. Oral Presentation
5	M. Sancar: Marmara Üniversitesinde Klinik Eczacılık. I. Ulusal Farmasötik Bakım ve Klinik Eczacılık Kongresi, İstanbul, Türkiye, 2005. Oral Presentation
6	Mertkan Turnacılar, Mesut Sancar, Şule Rabuş, Fikret Vehbi İzzettin: Tip 2 Diyabet Hastalarına Farmasötik Bakım Uygulanması: Hasta Eğitimi ve İzlemi. I. Ulusal Farmasötik Bakım ve Klinik Eczacılık Kongresi, İstanbul, Türkiye, 2005. Oral Presentation
7	Emel Mashaki, Mesut Sancar, Fikret Vehbi İzzettin: Doktorların ve Eczacıların Premenstruel Sendrom (PMS) ve Dismenore’ye Yaklaşımları ve İlaç Profili. I. Ulusal Farmasötik Bakım ve Klinik Eczacılık Kongresi, İstanbul, Türkiye, 2005. Oral Presentation
8	Şule Apikoğlu Rabuş, Mesut Sancar, Bülent Mutlu, Yelda Başaran, Cevat Yakut, Fikret Vehbi İzzettin: Kardiyovasküler Korumada Tanı-Tedavi Kılavuzlarının Karşılaştırılması – Farmakoterapötik Yaklaşım. I. Ulusal Farmasötik Bakım ve Klinik Eczacılık Kongresi, İstanbul, Türkiye, 2005.
9	Betül Yalçın, Mesut Sancar, Fikret Vehbi İzzettin: Yaşlılarda İlaç Profilinin Belirlenmesi ve Farmasötik Bakım İhtiyaçlarının Saptanması. I. Ulusal Farmasötik Bakım ve Klinik Eczacılık Kongresi, İstanbul, Türkiye, 2005. Oral Presentation
10	Emel Mashaki, Mesut Sancar, Fikret Vehbi İzzettin: Hastaların Adet Öncesi ve Adet Dönemindeki Şikayetlerinin Saptanması ve Kullandıkları İlaçların Profili. I. Ulusal Farmasötik Bakım ve Klinik Eczacılık Kongresi, İstanbul, Türkiye, 2005.
11	Neval Kapan, Mesut Sancar, Fikret V.İzzettin: Astım İlaçlarının Akılcı Kullanımında Klinik Eczacının Rolü ve Yazılı Eğitim. I. Ulusal Farmasötik Bakım ve Klinik Eczacılık Kongresi, İstanbul, Türkiye, 2005.
12	Sensu Bal, Mesut Sancar, Sule Rabus, Fikret Vehbi İzzettin: Samsun Gazi Bölgesindeki Hipertansiyon Hastalarının Özellikleri ve Kullandıkları İlaçlar. I. Ulusal Farmasötik Bakım ve Klinik Eczacılık Kongresi, İstanbul, Türkiye, 2005.
13	Fikret Vehbi İzzettin, Şule Apikoğlu Rabuş, Mesut Sancar, Mehmet Hurşitoğlu, Nuray Geboloğlu: Tip 2 Diyabette Kardiyovasküler Risk Kontrolü – Farmakoterapötik Yaklaşım. I. Ulusal Farmasötik Bakım ve Klinik Eczacılık Kongresi, İstanbul, Türkiye, 2005.
14	Betül Okuyan, Philip Clark, Sudabe Azarmir, Mesut Sancar, Fikret V. İzzettin: Tüberküloz Hastalarına Uygulanan Doğrudan Gözetim Tedavisinde Eczacının Rolü. I. Ulusal Farmasötik Bakım ve Klinik Eczacılık Kongresi, İstanbul, Türkiye, 2005.
15	Mesut Sancar: Helicobacter pylori İnfeksiyonu il Sigara ve Alkol Alışkanlığının İlişkisi. I. Ulusal Farmasötik Bakım ve Klinik Eczacılık Kongresi, İstanbul, Türkiye, 2005.
16	Mesut Sancar, Betül Okuyan, Şule Rabuş, Fikret Vehbi İzzettin: Türkiye’deki Serbest Eczacıların Farmasötik Bakım Uygulamaları Hakkındaki Görüşlerinin Değerlendirilmesi ve Engellerin Belirlenmesi. I. Ulusal Farmasötik Bakım ve Klinik Eczacılık Kongresi, İstanbul, Türkiye, 2005. Oral Presentation
17	M. Sancar, F.V. İzzettin: Avrupa’da Klinik Eczacılık: Avrupa Klinik Eczacılık Konferansı’ndan İzlenimler. 8. Türkiye Eczacılık Kongresi, Ankara, Türkiye, 2006. Oral Presentation
18	Ö. Carlı, M. Sancar, F.V. İzzettin: Kocaeli Bölgesindeki Pediatrik Pnömoni Vakalarında Antibiyotik Profili. 8. Türkiye Eczacılık Kongresi, Ankara, Türkiye, 2006.
19	B. Okuyan, M. Sancar, F.V. İzzettin: Antibiyotik Kullanımında Klinik Eczacının Rolleri ve Antibiyotiklerin İmmün Sistem Üzerine Etkileri. 8. Türkiye Eczacılık Kongresi, Ankara, Türkiye, 2006.
20	M. Sancar: Hastanelerde Klinik Eczacılık Uygulamaları. Hastane Eczaneleri Yönetimi Sempozyumu, Antalya, Türkiye, 2006. Oral Presentation
21	M. Sancar: Klinik Eczacılık Hizmetlerinin Farmakoekonomik Açıdan Değerlendirilmesi. İstanbul Eczacılık Kongresi, İstanbul, Türkiye, 2006. Oral Presentation
22	S. Eminzade, M. Sancar, B. Okuyan, F.V. İzzettin: Yaşam Kalitesinin Değerlendirilmesinde Klinik Eczacının Rolü. İstanbul Eczacılık Kongresi, İstanbul, Türkiye, 2006. Oral Presentation
	Top
Workshops
Workshops in International Meetings
1	Role of the pharmacists in upper respiratory tract infections, 7^th International Symposium on Pharmaceutical Sciences, Ankara, 2003.
2	Patient Education and Clinical Pharmacist 5. Pharmacy Fair, İstanbul, 2006.
3	How the pharmacist can be competent in Asthma Treatment, Workshop in ESCP 6^th Conference, Vilinus, 2006. Workshop Leader
4	Pharmaceutical care in Diabetes, Workshop in ESCP 6^th Conference, Vilinus, 2006.
5	Clinical Pharmacy Workshop (Practice in Hospital Setting). 8^th International Symposium on Pharmaceutical Sciences, Ankara, 2006.
	Top
Co-Advisor in Thesis
MSc Thesis
1	Outcomes of Pharmaceutical Care in Type II Diabetes: Patient Education and Monitoring. Mertkan Turnacılar, 2004
2	Comparison The Effect Of Different Drugs On Nonsteroidal Antiinflammatory Drug Induced Gastric Ulcer In Experimental Animals. Thaer Hantas, 2004.
3	Determination of Geriatric Patients’ Drug Profile and Identify Their Pharmaceutical Care Requirement, Betül Yalçın, 2005.
MSc Projects
1	Citalopram in Depression Management and The Role of Pharmacist Işıl İlknur Şahin, 2005.
2	The Role of Pharmacist in Monitoring of Infants’ Nutrition and Breastfeeding, Handan Ertung, 2005.
3	The Role of Pharmacist in Rational Usage of Asthma Drugs, Neval Kapan, 2005.
4	The Definition, General Assessment and Management of Obesity: The Role of Pharmacist:, Sani Özgüneş, 2005.
5	Assessment of Geriatric Patients’ Drug Profile in Narlıdere, İzmir, Berna Barut, 2005.
6	Drug Profiles of Patients with Hypertension in Gazi, Samsun, Şensu Bal, 2005.
7	Usage of Herbal Medicines in Liver and Biliary Disorders and Commercial Products in Community Pharmacies in Turkey Aysun Karadeniz, 2005.
8	Determination of Symptoms, Treatment Approaches and Drug Profiles in Premenstrual Syndrome and Dysmenorrhea, Emel Mashaki, 2005.
9	Pain Management and Patient Education in Rheumatismal Diseases, Pınar Erdem, 2005.
10	Drug Profiles of Hiperlipidemic Patients, Hülya Anlı, 2005.
11	The Antibiotic Profile of Pediatric Pneumoniae Cases seen in Kocaeli. Özgür Carlı, 2006.
12	The role of community pharmacist on oral and dental health: prevention of diseases and toothache management, Sabriye Tunç, 2007.
13	The Characteristics of Oncology Patients taking chemotherapy in a private hospital located in Gebze: Clinical Pharmacist’s Observation, M. Özge Gürbüz, 2007.
14	The Evaluation of Antibiotic Use in Nosocomial Infections seen in Intensive Care Unit of a Private Hospital located in Istanbul, Mustafa Özyalçın, 2007.
15	The Profile of The Cough and Other Side Effects Related to Using of Angiotensin-Converting Enzyme Inhibitors in The West Blacksea Region of Turkey, Berrin Yurdakul, 2007.
	Top
Projects
1	Nephrotoxicity of Different NSAI Drugs, Funded by Marmara Univ. 1998
2	International Drug Utilization Survey on Acute Myocardial İnfarcton Management – Collaborative Project, ESCP, 1998
3	Determination of Isoniaside, Pyrazinamide and Rifampisin Levels in Plazma and monitoring in Tuberculosis Patients. Marmara Univ. BAPKO 2005.
	Top
Awards
1	Poster Prize: ‘Effects of Ketorolac on Renal and Hematological Parameters’. Second International Clinical Pharmacy Conference, Amman, 1999.
2	Prize for Young Academicians: 3. Pharmacy Awards, İstanbul, 2006.
3	Marmara University Health Sciences Institue Awards for my article: ‘Effect of antituberculous drugs on human polymorphonuclear leukocyte functions in vitro. Int Immunopharmacol. 5(7-8):1337-42, 2005’, Istanbul 2007.
	Top